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Abstract
Background: There is mounting evidence that estimates of intakes of a range of dietary nutrients
are related to both lung function level and rate of decline, but far less evidence on the relation
between lung function and objective measures of serum levels of individual nutrients. The aim of
this study was to conduct a comprehensive examination of the independent associations of a wide
range of serum markers of nutritional status with lung function, measured as the one-second forced
expiratory volume (FEV1).
Methods: Using data from the Third National Health and Nutrition Examination Survey, a US
population-based cross-sectional study, we investigated the relation between 21 serum markers of
potentially relevant nutrients and FEV1, with adjustment for potential confounding factors.
Systematic approaches were used to guide the analysis.
Results: In a mutually adjusted model, higher serum levels of antioxidant vitamins (vitamin A, beta-
cryptoxanthin, vitamin C, vitamin E), selenium, normalized calcium, chloride, and iron were
independently associated with higher levels of FEV1. Higher concentrations of potassium and
sodium were associated with lower FEV1.
Conclusion: Maintaining higher serum concentrations of dietary antioxidant vitamins and selenium
is potentially beneficial to lung health. In addition other novel associations found in this study merit
further investigation.
Background
Chronic obstructive pulmonary disease (COPD) is a com-
mon disease characterised by reduced FEV1. Although
smoking is the main identified risk factor for COPD it is
clear that other aetiological factors are also involved.
There is now substantial observational evidence, based
predominantly on food frequency questionnaire meas-
ures of intake, that a diet high in antioxidants is associated
with better lung function [1-4]. However, a major rand-
omized controlled trial of supplementation with the main
antioxidant vitamins C, E, and beta-carotene recently
failed to identify any beneficial effect on COPD outcomes
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[5]. One possibility is that the effects of these particular
nutrients operate at an earlier point in the natural history
of COPD, or that the observational evidence is con-
founded by the effects of other nutrients or lifestyle fac-
tors, or it is possible that these nutrients do not have
universal benefit and only certain subgroups would bene-
fit from supplementation.
Much of the available epidemiological evidence is based
on findings using food frequency questionnaires to assess
diet. This method of assessing nutritional status has
potential limitations[6]. Serum nutrient levels provide an
alternative and objective measure of nutritional status,
but there are relatively few studies of the relation between
nutrients and lung function available [7-15] and these
have generally involved relatively small numbers of sub-
jects or else have studied the effects of only a limited
number of nutrients.
The aim of this study was therefore to use the comprehen-
sive data from the Third National Health and Nutrition
Survey (NHANES III) to extend an earlier investigation of
4 antioxidants (vitamin C, vitamin E, β-carotene, and sele-
nium) and lung function[7], and in addition, to investi-
gate the association of novel serum markers in relation to
lung function, measured as one-second forced expiratory
volume (FEV1), in an exploratory analyses.
Materials and methods
Between 1988 and 1994, a survey was conducted to exam-
ine the health and nutrition of a randomly selected sam-
ple of the non-institutionalized US population. Full
details of the survey design and examination procedure
have been previously published[16]. This study examines
adults aged 17 and older, which yields a study sample
population of 20,050. However, exclusions from the
study sample including missing data on lung function,
missing data on most of the exposure variables, or on any
confounding variables in the final model, resulted in a
final sample size of 14,120.
Data collection
Trained interviewers collected detailed information on
socioeconomic and medical history questionnaires on
each participant, including questions on social class,
smoking history, medical diagnosis, and current medica-
tion. Further measurements were conducted at mobile
examination centers, including anthropometric measure-
ments, which were used to calculate body mass index
(BMI (weight (kg) divided by height (m) squared)) and
waist to hip ratio (WHR). Complete medical examina-
tions were conducted and blood samples were collected
for a variety of biochemical assays, including vitamins
(vitamin A, alpha-carotene, beta-carotene, beta-cryptox-
anthin, lutein/zeaxanthin, lycopene, retinyl esters, vita-
min B12, red blood cell folate, vitamin C, and vitamin E),
minerals (selenium, normalised calcium, chloride, iron,
total iron binding capacity(TIBC), ferritin, transferrin sat-
uration, potassium, and sodium), total cholesterol, trig-
lycerides and total protein[17]. As part of the medical
examination, spirometry measurements including FEV1
and forced vital capacity (FVC) were conducted according
to the guidelines of the American Thoracic Society and the
highest value from the acceptable manoeuvres was
recorded. The present study has used the one-second
forced expiratory volume (FEV1) as its primary lung func-
tion outcome variable.
Statistical analyses
Self-reported smoking history was used to categorize par-
ticipants into never smokers, ex-smokers, and current
smokers. Data on cigarette consumption were used to
determine pack-years and prolonged periods in which a
person had quit smoking were accounted for in determin-
ing pack-years. BMI was also categorised into underweight
(BMI < 20), normal (≥ 20 BMI < 25), overweight (≥ 25
BMI < 30) and obese (BMI ≥ 30). A variety of models for
FEV1 were examined including ones with interaction and
higher order terms and as the results were similar for all of
them and the model fit was only marginally better with
the additional terms the simplest baseline model was cho-
sen which included age, sex, height, smoking (status and
pack-years), and race/ethnicity. In models including fat
soluble vitamins, serum triglycerides and total cholesterol
were additionally included in the model to adjust for their
confounding effect. Serum nutrient values were divided
into quintiles and fitted as ordered categorical variables
and unordered dummy variables to assess the linearity of
the relation. Nutrients showing a linear association with
FEV1 were then included in the analysis as continuous var-
iables and their effects calculated as change in FEV1 (in
mL) per standard deviation (SD) change in nutrient level.
Those showing nonlinear effects were modelled as cate-
gorical quintile variables. We examined the correlation
matrix and took this into account in subsequent model-
ling.
In our analyses we first divided the nutrients into 2
groups; an antioxidant group including vitamins and sele-
nium, all of which are potentially involved in antioxidant
defences, and a more diverse group of nutrients and bio-
logical mineral levels that have previously been or could
potentially be implicated in lung disease but with less
clearly established mechanisms of effect. We explored
independent effects initially within these two groups, first
modelling each nutrient alone to determine its unique
association with FEV1 (Model 1). Next using backward
and forward modelling, a mutually adjusted model was
created and then simplified to only include those varia-
bles that had statistically significant associations withRespiratory Research 2008, 9:67 http://respiratory-research.com/content/9/1/67
Page 3 of 10
(page number not for citation purposes)
FEV1(Model 2). Finally serum nutrient biomarkers were
combined across vitamins and minerals for a fully
adjusted model (Model 3). We also retained nutrients in
Model 2 if they had an independent, statistically signifi-
cant association with FEV1 in Model 3. We investigate
whether these models were affected by the correlation
between serum nutrients, and examined final models for
their validity of estimates given the potential effects of
multi-collinearity.
We investigated a number of potential confounding
effects including BMI, WHR, poverty index ratio, level of
education, physical activity, energy intake, passive smok-
ing, C-reactive protein and co-morbid conditions (includ-
ing heart disease, cancers, diabetes, and other conditions).
As there was a priori evidence to suggest that there may be
differences in associations according to smoking status,
we looked for evidence of effect modification by smoking
status and sex (in Model 1) on the individual nutrient
effects identified in Model 3. In addition, we examined
the data allowing for the multiple testing using Bonferroni
correction to the p-values. All results presented were con-
ducted whilst accounting for the complex, multi-stage
probability sample design of NHANES III and all data
were analyzed using STATA SE 9.0 (Stata Corporation,
Texas).
Results
There were 6,671 (47.3%) males in the study population
and 7,449 (52.8%) females (Table 1). Analysis of availa-
ble data for participants excluded as a result of incomplete
data indicated that they were slightly older, with a mean
age of 52.0 as compared to 45.7, and included a slightly
higher proportion of ex-smokers, but appeared otherwise
to be broadly similar to those with complete data. Demo-
graphic data were similar also for the study population
with data available for vitamin B12 (n = 7360) and nor-
malised calcium (n = 12657). Mean serum nutrient levels
and their standard deviations are shown in Table 2.
In models considering single nutrients in the antioxidant
group, vitamin A, retinyl esters, alpha-carotene, beta-caro-
tene, beta-cryptoxanthin, lutein/zeaxanthin, lycopene,
vitamin C, vitamin E and selenium were each associated
with FEV1 (Table 3, Model 1). In the mutually adjusted
Model 2, some of these regression coefficients were atten-
Table 1: Demographics and characteristics of the study population and those subjects excluded from the study*
Variable Participants included
N = 14120
Participants excluded
N = 5930
Mean (SD) Number (%) Mean (SD) Number (%)
Sex
Males 6671 (47.3) 2730 (47.8)
Females 7449 (52.8) 3200 (54.0)
Age 45.7 (19.6) 52.0 (22.8)
Smoking status
Never 7390 (52.3) 2845 (48.1)
Ex 3174 (22.5) 1633 (27.6)
Current 3556 (25.2) 1434 (24.3)
Pack Years** 0 (0 to 12) 0 (0 to 14)
Race/Ethnicity
Non-Hispanic White 5881 (41.6) 2602 (43.9)
Non-Hispanic Black 3860 (27.3) 1626 (27.4)
Mexican-American 3802 (26.9) 1504 (25.4)
Other 577 (4.1) 198 (3.3)
FEV1 (L) 3.0 (0.9) 2.8 (1.0)
FVC (L) 3.8 (1.1) 3.6 (1.1)
BMI (kg/m2) 27.0 (5.8) 26.6 (6.2)
Cholesterol (mmol/l) 5.3 (1.2) 5.3 (1.2)
Triglycerides (mmol/l) 1.6 (1.3) 1.7 (1.3)
Energy intake (kcal) 2102 (1068) 2006 (1039)
C-reactive protein (mg/dL)** 0.21 (0.21 to 0.40) 0.21 (0.21 to 0.51)
Activity level
None 2800 (19.8) 1886 (31.8)
Low 5867 (41.6) 2012 (33.9)
Moderate 4579 (32.4) 1741 (29.4)
High 874 (6.2) 291 (4.9)
* Data is presented for the population where data is available. Excluded participants had missing data on a priori confounders and/or serum markers
** Data presented as Median and IQRRespiratory Research 2008, 9:67 http://respiratory-research.com/content/9/1/67
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uated; however vitamin A retained a relatively strong asso-
ciation with FEV1  (increase per standard deviation
increase in vitamin A = 31.2 mL, 95% CI 21.8 to 40.5), as
did selenium, the difference in FEV1 between persons in
the highest vs. lowest quintiles was 60.1 mL (95% CI 34.0
to 86.2). There was little or no change in these regression
coefficients after further adjusting for serum markers that
had statistically significant effects in the minerals and
other nutrients regression model (Table 3, Model 3).
In univariate analysis of minerals and other nutrients,
normalised calcium, chloride, iron, transferrin saturation,
red blood cell folate, potassium, sodium and total protein
were statistically significantly associated with FEV1 (Table
4, Model 1). In the mutually adjusted Model 2, normal-
ised calcium had an inverse U-shaped relation with FEV1,
as the third and fourth quintiles were associated with bet-
ter lung function compared to the second and fifth quin-
tiles. A higher concentration of serum chloride was
associated with higher FEV1 (FEV1 difference per standard
deviation increase in chloride = 35.6 mL, 95% CI 22.8 to
48.5). Although there was not a clear dose-response rela-
tion, serum iron also had a positive association with FEV1,
such that persons in the highest quintile of iron had an
average FEV1 that was 77.8 ml higher (95% CI 45.5 to
110.0) than persons in the lowest quintile. There was a
very strong correlation between iron and transferrin satu-
ration (r = 0.92) and when put in Model 2 without iron in
the model, each standard deviation increase in transferrin
saturation was associated with a 20.9 mL (95% 10.9 to
30.9) increase in FEV1. Serum potassium had an inverse
association with FEV1, the FEV1 difference per standard
deviation change in potassium was -15.6 mL (95% CI -
22.1 to -9.0), and there was also an inverse association
with sodium (FEV1 difference per standard deviation = -
10.1 mL, 95% CI -21.0 to 0.72). Associations in the min-
eral and other nutrient group were not appreciably altered
by adjusting for antioxidant nutrients.
We investigated potential confounding by a number of
other factors including waist to hip ratio (WHR), poverty
index ratio, level of education, physical activity, energy
intake, passive smoking, C-reactive protein and co-mor-
bid illness. The further consideration of these variables
had no notable effect on the estimates: the majority of
model coefficients were within 5% of their original value
when further variables were added to the model. We also
looked for evidence of effect modification by smoking sta-
tus and found statistical evidence for a smoking by nutri-
ent interactions for vitamin A, lycopene, red blood cell
folate, chloride and vitamin E. Lycopene and red blood
cell folate did not have a consistent association pattern
across smoking categories, whereas vitamin A, chloride,
and vitamin E all showed a stronger association with FEV1
among current smokers (Table 5). We have examined the
data for interactions with sex, and found significant inter-
actions for lycopene, selenium and chloride, all of which
had a greater effect in men than in women (data not
shown).
Finally, we conducted sensitivity analyses to examine
whether the results were similar after the exclusions of
selected participants. When the results were examined
excluding individuals who used vitamin or mineral sup-
plements (n = 5149, 36%), the majority of the results were
similar; increases in the effect size were seen for vitamin E
and iron, whereas the effect sizes for lycopene and sele-
nium were slightly reduced. Excluding people with
asthma (n = 991, 7%) from the study population did not
alter the effect estimates. Excluding participants with
COPD (n = 989, 9%) [self-reported physician-diagnosed
emphysema and/or chronic bronchitis, and/or by GOLD
spirometry criteria (FEV1/FVC < 70% and FEV1 < 80% pre-
dicted although not post-bronchodilator)], yielded effect
sizes that were reduced slightly, but did not affect the
overall conclusions of the analysis. Similar conclusions
were made when lung function was modelled as FVC.
When we examined the correlation matrix between serum
nutrients the vast majority had very weak correlations,
Table 2: Mean levels of serum nutrients in the study population
Nutrient Mean SD
Antioxidants
Vitamin A (μmol/L) 1.98 0.58
Alpha-carotene (μmol/L) 0.08 0.10
Beta-carotene (μmol/L) 0.37 0.40
Beta-cryptoxanthin (μmol/L) 0.19 0.15
Lutein/zeaxanthin (μmol/L) 0.40 0.23
Lycopene (μmol/L) 0.41 0.21
Retinyl Esters (μmol/L)* 0.19 0.15
Vitamin B12 (pmol/L) 444.9 1913.8
Vitamin C (mmol/L) 40.2 25.4
Vitamin E (μmol/L) 26.0 11.6
Selenium (nmol/L) 1.6 0.2
Minerals and other nutrients
Normalised calcium (mmol/L)** 1.24 0.05
Chloride (mmol/L) 104.5 3.3
Iron (μmol/L) 15.7 6.7
TIBC (μmol/L) 63.5 10.4
Transferrin saturation (%) 25.4 11.4
Ferritin (μg/L) 129.3 143.8
Red blood cell folate (nmol/L) 420.1 229.5
Potassium (mmo/L) 4.1 0.3
Sodium (mmol/L) 141.3 2.4
Total Protein (g/L) 74.0 5.0
* Data available only for 7360 participants
**Data available only for 12657 participantsRespiratory Research 2008, 9:67 http://respiratory-research.com/content/9/1/67
Page 5 of 10
(page number not for citation purposes)
and the only strong correlation (r > 0.6) was found
between iron and transferrin saturation: these two nutri-
ents were never included in the same model. Within
Model 3, 95% of the correlations between nutrients were
less than 0.3 and the strongest correlation found was
between lutein/zeaxanthin and beta-cryptoxanthin (r =
Table 3: Difference in FEV1 for a one SD or quintile increase in antioxidants
Nutrient Model as Model 1* Model 2† Model 3‡
β coeff 95% CI β coeff 95% CI β coeff 95% CI
Vitamin A (μmol/L) Per SD change 42.6 32.4 to 52.9 31.2 21.8 to 40.5 33.1 23.7 to 42.6
p < 0.001
Alpha-carotene (μmol/L) Per SD change 23.7 6.4 to 41.1
Beta-carotene (μmol/L) Per SD change 25.5 16.3 to 34.7
Beta-cryptoxanthin (μmol/L) ≤ 0.09 reference reference reference
0.10 – 0.13 44.9 19.4 to 70.4 20.9 -3.4 to 45.3 26.4 -0.3 to 53.0
0.14 – 0.18 93.6 68.0 to 119.3 57.1 31.2 to 82.9 57.1 30.8 to 83.5
0.19 – 0.25 94.6 63.4 to 125.9 50.7 22.6 to 78.8 60.4 25.7 to 95.0
≥ 0.26 110.7 78.2 to 143.2 52.3 22.1 to 82.5 66.3 31.5 to 101.6
p = 0.004
Lutein/Zeaxanthin (μmol/L) Per SD change 29.2 16.2 to 42.3 14.1 4.6 to 23.6 8.6 -1.5 to 18.6
p = 0.092
Lycopene (μmol/L)) ≤ 0.22 reference reference reference
0.23 – 0.34 52.8 25.1 to 80.6 35.9 11.3 to 60.5 33.8 5.2 to 62.5
0.35 – 0.43 63.7 39.8 to 87.6 39.2 12.1 to 66.2 35.6 10.0 to 61.1
0.44 – 0.58 70.5 40.1 to 100.9 40.0 13.4 to 66.5 36.9 7.9 to 65.9
≥ 0.59 88.0 59.9 to 116.2 48.9 19.9 to 77.9 54.3 25.0 to 83.6
p = 0.01
Retinyl Esters (μmol/L) Per SD change 23.5 11.9 to 35.0
Vitamin B12 (pmol/L) ≤ 239.1 reference
239.2 – 304.0 4.4 -30.2 to 39.1
304.1 – 374.8 -9.3 -43.7 to 25.0
374.9 – 478.1 -7.2 -42.0 to 27.5
≥ 478.2 -29.7 -64.5 to 5.2
Vitamin C (mmol/L) Per SD change 38.1 28.1 to 48.0 17.0 6.8 to 27.3 17.9 7.5 to 28.2
p < 0.001
Vitamin E (μmol/L) Per SD change 45.6 32.9 to 58.3 23.1 11.5 to 34.7 25.3 12.3 to 38.4
p < 0.001
Selenium (nmol/L) ≤ 1.4 reference reference reference
1.41 – 1.5 50.0 23.5 to 76.6 40.5 15.5 to 65.5 43.4 13.6 to 73.1
1.51 – 1.6 61.1 33.8 to 88.4 48.5 23.8 to 73.3 57.0 29.5 to 84.5
1.61 – 1.73 89.9 61.1 to 118.7 73.1 48.0 to 98.3 76.7 47.1 to 106.4
≥ 1.74 80.4 50.5 to 110.2 60.1 34.0 to 86.2 68.6 34.8 to 102.4
0.002
*Model 1- Adjusted for age, sex, height, smoking (status and packyears), BMI, race/ethnicity and fat-soluble vitamins adjusted for cholesterol and 
triglycerides, considering the nutrients individually
†Model 2- Adjusted for covariates listed under Model 1, as well as for all nutrients with statistically significant associations with lung function in a 
mutually adjusted model. Number of participants in model = 14120
‡Model 3- Adjusted for all covariates and nutrients in Model 1 & 2 and additionally adjusted for minerals and other nutrients found to be 
significantly associated with lung function (model 2) in Table 4. Number of participants in model = 12657Respiratory Research 2008, 9:67 http://respiratory-research.com/content/9/1/67
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0.50), however modelling them separately did not alter
findings; it only increased the size of the effects in the final
model. The final model was examined for collinearity and
there was no strong evidence of collinearity within the
model as all of the variance inflation factors were less than
5 and the mean variation inflation factor was 1.86. Lastly,
if we apply the Bonferoni correction to the p-values, then
only p-values of less than 0.002 would be considered as
statistically significant. This multiple comparison
approach would have excluded the following nutrients
Table 4: Difference in FEV1 for a one SD or quintile increase in minerals and other nutrients
Nutrient Model as Model 1* Model 2† Model 3‡
β coeff 95% CI β coeff 95% CI β coeff 95% CI
Normalised calcium 
(mmol/l)
≤ 2.23 reference reference reference
2.24 – 2.29 38.9 11.9 to 65.9 41.2 14.8 to 67.5 36.5 10.3 to 62.7
2.30 – 2.33 68.5 43.9 to 93.0 71.8 47.1 to 96.5 64.1 39.5 to 88.6
2.34 – 2.39 50.3 19.6 to 80.9 58.5 28.3 to 88.6 50.3 19.6 to 80.9
≥ 2.4 25.8 -6.5 to 58.0 39.4 7.1 to 72.5 29.0 -1.0 to 52.7
p = 0.001
Chloride (mmol/L) Per SD change 27.2 17.9 to 36.5 35.6 22.8 to 48.5 40.5 28.4 to 52.7
p < 0.001
Iron (μmol/L) ≤ 10.21 reference reference reference
10.22 – 13.43 33.6 8.9 to 58.3 37.5 11.5 to 63.5 23.3 -3.6 to 50.2
13.44 – 16.48 68.0 43.1 to 92.8 72.2 46.1 to 98.2 51.0 23.9 to 78.2
16.49 – 20.6 51.8 29.1 to 74.6 58.0 35.5 to 80.5 35.2 12.9 to 57.6
≥ 20.61 70.8 40.1 to 101.6 77.8 45.5 to 110.0 54.2 21.0 to 86.4
p = 0.0054
TIBC (μmol/L) ≤ 54.98 reference
54.99 – 60.36 12.8 -13.0 to 38.6
60.37 – 65.19 19.1 -2.9 to 41.0
65.20 – 71.82 3.1 -24.9 to 31.0
≥ 71.83 -25.4 -52.7 to 1.9
Transferrin saturation 
(%)
Per SD change 24.2 14.2 to 34.2
Ferritin (μmol/L) Per SD change 3.4 -5.1 to 12.0
Red blood cell folate 
(nmol/L)
≤ 256.1 256.2 – 326.3 reference 40.4 16.9 to 63.8 reference 41.1 16.8 to 65.3 reference 27.4 3.9 to 51.0
326.4 – 407.9 33.3 4.5 to 62.1 29.7 1.0 to 58.4 9.3 -18.2 to 36.8
408.0 – 555.2 43.3 16.9 to 69.7 45.5 17.1 to 73.9 14.1 -13.9 to 42.2
≥ 555.3 36.3 8.0 to 64.6 34.3 2.8 to 65.8 -13.2 -45.1 to 18.7
p = 0.0207
Potassium (mmol/l) Per SD change -10.7 -18.2 to -3.1 -15.6 -22.1 to -9.0 -21.2 -28.3 to -14.1
p < 0.001
Sodium (mmol/l) Per SD change 6.6 -0.9 to 14.0 -10.1 -21.0 to 0.72 -13.0 -24.1 to -2.0
p = 0.022
Total Protein (g/L) Per SD change -17.2 -28.5 to -5.9
* Model 1- Adjusted for age, sex, height, smoking (status and packyears), BMI, race/ethnicity
† Model 2- Adjusted for covariates listed under Model 1, as well as for all nutrients with statistically significant associations with lung function in a 
mutually adjusted model. Number of participants in model = 14120
‡ Model 3- Adjusted for all covariates and nutrients in Model 1 & 2 and additionally adjusted for minerals and other nutrients found to be 
significantly associated with lung function (model 2) in Table 3. Number of participants in model = 12657Respiratory Research 2008, 9:67 http://respiratory-research.com/content/9/1/67
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from the final model lutein/zeaxanthin (p = 0.092), lyco-
pene (p = 0.01) iron (p = 0.005), red blood cell folate (p
= 0.021), and sodium (p = 0.022).
Discussion
There is already an extensive literature on the relation
between measures of dietary intake, lung function and
various other respiratory disease outcomes, which has
been reviewed elsewhere[1,2,4,18,19], but relatively few
of the available studies have explored the effects of serum
nutrient markers. Most previous studies have also investi-
gated the effects of a particular nutrient or nutrient group,
and are thus open to error arising from confounding
effects of other nutrients. In this study we have used the
extensive NHANES III dataset in a systematic analysis of
all available levels of nutrients and minerals available
within the dataset and have used a stepwise grouped anal-
ysis to identify independently significant effects on FEV1.
The a priori objective of this study was to test all available
serum nutrients in the NHANES III dataset in a single
model, to identify the relative importance of individual
nutrients, and the statistical power available in the dataset
has allowed us to distinguish independent effects of sev-
eral exposures. In addition, the majority of the nutrients
had very weak correlations with other serum nutrients. A
systematic approach to modelling was taken and one of
the explicit goals of the analyses was to discover new asso-
ciations. Most of the p-values were very small (p < 0.002),
however if we applied the conservative approach of the
Bonferroni correction, 4 of the nutrients in the final
model would no longer be considered statistically signifi-
cant. However, the results from this approach must also
be interpreted with caution due to the potential of type II
error[20]. Similar to previous studies, the effects of some
of antioxidants were stronger in smokers as compared to
non-smokers. Although the levels of serum markers in
males and females were similar, the effect of a few of the
antioxidants appeared to be stronger in males compared
to females, and these interactions need to be confirmed in
other datasets.
Although all of the nutrient levels we analysed are
dependent at least to some degree on dietary intake, some
(such as sodium and calcium) are closely regulated by
homeostatic systems in the body, so in these and in some
other cases levels are likely to be low only when intake is
extremely low. However we have included these nutrients
in the analysis since all have potential links with lung
defences, airway calibre or other factors relevant to COPD.
In addition, for the majority of study participants, the diet
Table 5: Stratified analyses of smoking with certain nutrients*
Nutrient Non-smokers Ex-Smokers Current Smokers
β coeff 95% CI β coeff 95% CI β coeff 95% CI
Vitamin A (μmol/L) Per SD change 15.9 -0.8 to 32.6 24.6 6.3 to 42.9 51.8 35.4 to 68.3
p < 0.001
Lycopene (μmol/L) ≤ 0.22 reference reference reference
0.23 – 0.34 55.8 26.1 to 85.5 0.4 -60.8 to 61.6 26.3 -29.0 to 81.6
0.35 – 0.43 45.4 12.9 to 77.9 31.0 -29.7 to 91.7 15.2 -44.4 to 74.8
0.44 – 0.58 37.7 -1.7 to 77.2 25.2 -24.3 to 74.6 50.1 -9.4 to 109.6
≥ 0.59 52.3 13.0 to 91.7 92.0 31.3 to 152.7 31.4 -28.3 to 91.1
p = 0.59
Vitamin E (μmol/L) Per SD change 17.8 1.8 to 33.9 28.4 12.1 to 44.8 39.7 9.5 to 69.9
p = 0.011
Chloride (mmol/L) Per SD change 29.8 16.2 to 43.3 51.0 28.0 to 73.9 59.4 29.8 to 89.0
p < 0.001
Red blood cell folate (nmol/L) ≤ 256.1 reference reference reference
256.2 – 326.3 28.5 -8.9 to 61.8 23.7 -49.0 to 96.5 34.4 -24.5 to 93.3
326.4 – 407.9 5.0 -34.7 to 44.8 36.7 -28.7 to 102.8 -0.7 -48.0 to 46.6
408.0 – 555.2 12.7 -25.9 to 51.3 3.3 -69.3 to 75.9 28.8 -30.3 to 88.0
≥ 555.3 -0.3 -42.7 to 42.6 -22.9 -99.2 to 53.3 -0.8 -76.2 to 74.6
p = 0.58
* adjusted for age, sex, height, packyears (where appropriate), BMI, race/ethnicity and fat-soluble vitamins adjusted for cholesterol, triglycerides, and 
other important nutrientsRespiratory Research 2008, 9:67 http://respiratory-research.com/content/9/1/67
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will tend to track through their lifetime, and therefore
these cross-sectional relations are important to investi-
gate.
We found that in our mutually adjusted models, FEV1 was
independently and directly related to levels of vitamin A,
beta-cryptoxanthin, lutein/zeaxanthin, lycopene, vitamin
C, vitamin E, selenium, normalised calcium, chloride and
iron, and was inversely related to potassium and sodium.
Of nutrients with linear associations with FEV1 the strong-
est effects per standard deviation change were evident for
chloride and vitamin A. Of variables with non-linear asso-
ciations, the strongest category effects were seen with beta-
cryptoxanthin and selenium.
Our findings for the nutrients in the antioxidant group
were predictably similar to previous findings from a less
extensive analysis of data from NHANES III [7], with vita-
min C, vitamin E and selenium identified as independent
predictors of FEV1, but after adjustment for these nutrients
the effect serum beta-carotene was not independently
associated with lung function in both analyses of the data.
If lung function is modelled in a similar fashion to the
prior paper, the effect sizes for vitamin C, vitamin E and
selenium are similar to the previously published mutu-
ally-adjusted model even after adjustment for the other
serum antioxidants that were associated with lung func-
tion. This finding is consistent with a relatively predomi-
nant role of vitamin C in serum and interstitial fluid in
maintaining membrane-bound vitamin E in a reduced
state [21]. Three other studies of either serum or plasma
vitamin C have reported a protective effect on
FEV1[9,13,15], though this was not confirmed in one
study [8]. There is less evidence of a positive relation
between serum vitamin E and FEV1 [8], with the majority
studies finding no association [9,10,15,22]. Previous
results have found protective effects for vitamin A, beta-
cryptoxanthin, retinol, total carotenoids, alpha-carotene
and beta carotene [8,10,12,14,22].
A growing body of evidence suggests that higher levels of
selenium are associated with a reduced risk of asthma [23-
30], but the evidence on the relation of selenium to
COPD is much more limited. One other population-
based study in Nottingham, UK has investigated this asso-
ciation and found that higher levels of serum selenium
were associated with higher lung function [15]. The role
of selenium in antioxidant defence through the glutath-
ione peroxidase activity is now well established however,
and it is therefore plausible that selenium intake is an
important determinant of lung defence against damage
from cigarette smoke and other environmental pollutants
contributing to the aetiology of COPD. The role of sele-
nium therefore deserves further study in randomised con-
trolled trials.
Our analysis of mineral effects found strong effects of
serum chloride and sodium on FEV1, and we are not
aware of any previous reports of these associations. There
is substantial literature suggesting an association between
sodium intake and self-reported asthma and/or other res-
piratory symptoms [31-33], exercise induced asthma [34-
37], and airway hyper responsiveness[38,39], although
not all studies support these findings [31,40-44]. The
mechanism of this association in asthma is not under-
stood however, and other studies have not found a rela-
tion between sodium intake and FEV1 [43,45]. There are
no previous reports of an association between serum chlo-
ride and FEV1, and an intervention study in exercise-
induced asthma reported findings that contradict ours, in
that dietary chloride was associated with a reduction in
lung function after an exercise challenge test [36]. Our
findings are based on serum levels of sodium and chlo-
ride, which are predominantly under hormonal and renal
control and relatively insensitive to dietary intake, but the
strength of the associations indicate that they deserve fur-
ther investigation.
Our finding of a negative association between FEV1 and
serum potassium level is also, to our knowledge, new. It is
also consistent with reported associations between
increased urinary potassium and increased airway hyper-
responsiveness[31,46] and also lower lung function in
girls [45], but two other studies have found no association
with serum potassium and asthma [47,48] and one has
reported evidence of an opposite effects, such that lower
levels of serum potassium were associated with a greater
risk of asthma[49].
To our knowledge the associations reported herein
between lung function and serum levels of iron, calcium
and folate have not previously been reported, though all
have biologically plausible effects on the lung. In the case
of iron, effects may be mediated through peripheral
involvement in antioxidant processes [50-55], whilst a
protective effect of calcium could be explained by an inter-
action with the effects of magnesium, which influence
intracellular calcium levels and in so doing affects smooth
muscle tone [56]. There is evidence that dietary magne-
sium has a protective effect on lung function but serum
magnesium data were not available in NHANES III
[57,58]. Folate has been reported elsewhere to be low in
cases of asthma relative to controls[59], and our results
generally support that increased red blood cell folate is
positively associated with the FEV1.
Conclusion
To summarise, our study confirms that antioxidant levels
in blood are associated with higher levels of FEV1 and
hence may mediate reduced susceptibility to COPD. In
addition to the antioxidant vitamins, selenium is alsoRespiratory Research 2008, 9:67 http://respiratory-research.com/content/9/1/67
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potentially important. Although the effects of the antioxi-
dant vitamins have been recognised for some time, the
potential beneficial role of selenium deserves further
investigation. Likewise, our finding that sodium, chloride
and potassium levels are also related to lung function
needs to be tested in other datasets, and if confirmed, the
relative importance of intake and homeostatic control
mechanisms investigated.
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